These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32407843)

  • 21. DNA methylation profiling identifies epigenetic signatures of early gastric cancer.
    Shi Z; Guo X; Hu X; Li R; Li X; Lu J; Jin M; Jiang X
    Virchows Arch; 2024 Apr; 484(4):687-695. PubMed ID: 38507065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome.
    Ma G; Liu H; Hua Q; Wang M; Du M; Lin Y; Ge Y; Gong W; Zhao Q; Qiang F; Tao G; Zhang Z; Chu H
    Mol Cancer; 2017 Feb; 16(1):46. PubMed ID: 28231797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and Validation of Novel Methylation Markers in
    Wang H; Li NS; He C; Xie C; Zhu Y; Lu NH; Hu Y
    Dis Markers; 2021; 2021():4391133. PubMed ID: 34925643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GHSR DNA hypermethylation is a new epigenetic biomarker for gastric adenocarcinoma and beyond.
    Amini M; Foroughi K; Talebi F; Aghagolzade Haji H; Kamali F; Jandaghi P; Hoheisel JD; Manoochehri M
    J Cell Physiol; 2019 Sep; 234(9):15320-15329. PubMed ID: 30677130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation of RNA-binding protein for multiple splicing 2 functions as diagnosis biomarker in gastric cancer pathogenesis and its potential clinical significance.
    Cheng M; Zhan X; Xu Y; Wang S; Zhang H; Fang L; Jin H; Chen W
    Bioengineered; 2022 Feb; 13(2):4347-4360. PubMed ID: 35137653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
    Kanda M; Shimizu D; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncotarget; 2016 Mar; 7(12):13667-79. PubMed ID: 26872374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation signatures associated with prognosis of gastric cancer.
    Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
    BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients.
    Ng EK; Leung CP; Shin VY; Wong CL; Ma ES; Jin HC; Chu KM; Kwong A
    PLoS One; 2011; 6(7):e22233. PubMed ID: 21789241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer.
    Wei KL; Chou JL; Chen YC; Jin H; Chuang YM; Wu CS; Chan MWY
    PLoS One; 2019; 14(6):e0218338. PubMed ID: 31194837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypermethylation in gastric cancer.
    Li Y; Liang J; Hou P
    Clin Chim Acta; 2015 Aug; 448():124-32. PubMed ID: 26148722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
    Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating FGFR2 gene as a blood-based epigenetic biomarker in gastric cancer.
    Aleyasin SA; Moradi A; Abolhasani N; Abdollahi M
    Mol Biol Rep; 2024 Feb; 51(1):253. PubMed ID: 38302798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypermethylation of EIF4E promoter is associated with early onset of gastric cancer.
    Ge Y; Wu Q; Ma G; Shao W; Liu H; Zhang Q; Xin J; Xue Y; Du M; Zhao Q; Wang M; Chu H; Zhang Z
    Carcinogenesis; 2018 Jan; 39(1):66-71. PubMed ID: 29342273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers.
    Vedeld HM; Andresen K; Eilertsen IA; Nesbakken A; Seruca R; Gladhaug IP; Thiis-Evensen E; Rognum TO; Boberg KM; Lind GE
    Int J Cancer; 2015 Feb; 136(4):844-53. PubMed ID: 24948044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer.
    Buffart TE; Overmeer RM; Steenbergen RD; Tijssen M; van Grieken NC; Snijders PJ; Grabsch HI; van de Velde CJ; Carvalho B; Meijer GA
    Br J Cancer; 2008 Dec; 99(11):1802-7. PubMed ID: 19002170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies.
    Haldrup C; Pedersen AL; Øgaard N; Strand SH; Høyer S; Borre M; Ørntoft TF; Sørensen KD
    Mol Oncol; 2018 Apr; 12(4):545-560. PubMed ID: 29465788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.
    Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ
    Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.